Associated clinical abnormalities among patients with Turner syndrome.
Associated abnormalities
Turner syndrome
clinical features
diagnosis
Journal
Northern clinics of Istanbul
ISSN: 2536-4553
Titre abrégé: North Clin Istanb
Pays: Turkey
ID NLM: 101684520
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
11
2018
accepted:
01
08
2019
entrez:
2
6
2020
pubmed:
2
6
2020
medline:
2
6
2020
Statut:
epublish
Résumé
The early diagnosis of Turner syndrome (TS) is often difficult because of the various clinical features. This study aimed to investigate clinical features and identify associated abnormalities in a group of patients with TS. Retrospective data of presenting clinical features collected from the medical records of the 37 patients with TS. All patients were examined for associated clinical abnormalities. Mean age at diagnosis was 9.3±4.1 years. The main reason for referral was short stature and/or delayed puberty. All of the patients had at least one dysmorphic sign. Skeletal system abnormalities (57%) were the most common associated abnormality, which was followed by gastrointestinal system problems (40%). Cardiac defects occurred in 32%. Urinary system abnormalities occurred in 27%. Dermatological problems were detected in 32% of the patients. The pathology of the hearing was found in 19%. Autoimmune thyroid disease was detected in 24% of the patients, and celiac disease was detected in 5.4% of the patients. Phenotypic variability often leads to a delay in the diagnosis of TS. Early diagnosis can initiate effective management in patients with TS.
Identifiants
pubmed: 32478293
doi: 10.14744/nci.2019.84758
pii: NCI-7-226
pmc: PMC7251269
doi:
Types de publication
Journal Article
Langues
eng
Pagination
226-230Informations de copyright
Copyright: © 2020 by Istanbul Northern Anatolian Association of Public Hospitals.
Déclaration de conflit d'intérêts
Conflict of Interest: No conflict of interest was declared by the authors.
Références
Eur J Endocrinol. 2017 Sep;177(3):G1-G70
pubmed: 28705803
Arch Dis Child. 2005 Mar;90(3):267-8
pubmed: 15723912
J Clin Endocrinol Metab. 2007 Jan;92(1):10-25
pubmed: 17047017
J Clin Epidemiol. 1998 Feb;51(2):147-58
pubmed: 9474075
Br J Dermatol. 1998 Jun;138(6):993-7
pubmed: 9747360
J Clin Endocrinol Metab. 2002 Dec;87(12):5495-8
pubmed: 12466343
Eur J Endocrinol. 2004 Dec;151(6):657-87
pubmed: 15588233
N Engl J Med. 2004 Sep 16;351(12):1227-38
pubmed: 15371580
J Clin Endocrinol Metab. 2006 Oct;91(10):3897-902
pubmed: 16849410
J Clin Res Pediatr Endocrinol. 2015 Mar;7(1):27-36
pubmed: 25800473
Int J Pediatr Endocrinol. 2018;2018:4
pubmed: 29983717
Acta Paediatr. 1995 Aug;84(8):909-12
pubmed: 7488816
Eur J Phys Rehabil Med. 2011 Sep;47(3):447-53
pubmed: 21508910
JAMA Dermatol. 2013 May;149(5):559-64
pubmed: 23426075
Pediatrics. 1999 Oct;104(4 Pt 2):1045-50
pubmed: 10506263
Endocr Rev. 2002 Feb;23(1):120-40
pubmed: 11844747
N Engl J Med. 1996 Dec 5;335(23):1749-54
pubmed: 8929268
Otol Neurotol. 2005 Mar;26(2):145-50
pubmed: 15793396
Lancet. 1993 Jun 12;341(8859):1505-6
pubmed: 8099381
Arch Dis Child. 1994 Nov;71(5):433-6
pubmed: 7826114
Int J Dermatol. 2014 Jan;53(1):e29-32
pubmed: 23231376
J Clin Endocrinol Metab. 2001 Jul;86(7):3061-9
pubmed: 11443168
Minerva Endocrinol. 2007 Dec;32(4):245-61
pubmed: 18091662
Ther Clin Risk Manag. 2017 May 04;13:613-622
pubmed: 28496331
J Am Acad Dermatol. 2004 Sep;51(3):354-8
pubmed: 15337976